Výsledky vyhledávání - Shilpak Chatterjee

  • Zobrazuji výsledky 1 - 18 z 18
Upřesnit hledání
  1. 1
    CD38: T Cell Immuno-Metabolic Modulator

    CD38: T Cell Immuno-Metabolic Modulator Autor Anwesha Kar, Shikhar Mehrotra, Shilpak Chatterjee

    Vydáno 2020
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  2. 2
    Deletion of Pim kinases elevates the cellular levels of reactive oxygen species and sensitizes to K-Ras-induced cell killing

    Deletion of Pim kinases elevates the cellular levels of reactive oxygen species and sensitizes to K-Ras-induced cell killing Autor Jin H. Song, Ningfei An, Shilpak Chatterjee, Emily Kistner‐Griffin, Sandeep Mahajan, Shikhar Mehrotra, Andrew S. Kraft

    Vydáno 2014
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  3. 3
    CCL22 to Activate Treg Migration and Suppress Depigmentation in Vitiligo

    CCL22 to Activate Treg Migration and Suppress Depigmentation in Vitiligo Autor Jonathan M. Eby, Hee-Kap Kang, Sean T. Tully, Wendy Bindeman, Daniel S. Peiffer, Shilpak Chatterjee, Shikhar Mehrotra, I. Caroline Le Poole

    Vydáno 2015
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  4. 4
    A novel copper complex induces ROS generation in doxorubicin resistant Ehrlich ascitis carcinoma cells and increases activity of antioxidant enzymes in vital organs in vivo

    A novel copper complex induces ROS generation in doxorubicin resistant Ehrlich ascitis carcinoma cells and increases activity of antioxidant enzymes in vital organs in vivo Autor Ananda Mookerjee, Jayati Basu, Surajit Majumder, Shilpak Chatterjee, Gouri Sankar Panda, Pranabananda Dutta, Smarajit Pal, Pratima Mukherjee, Thomas Efferth, Syamal Roy, Soumitra Kumar Choudhuri

    Vydáno 2006
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  5. 5
    Reducing CD73 Expression by IL1β-Programmed Th17 Cells Improves Immunotherapeutic Control of Tumors

    Reducing CD73 Expression by IL1β-Programmed Th17 Cells Improves Immunotherapeutic Control of Tumors Autor Shilpak Chatterjee, Krishnamurthy Thyagarajan, Pravin Kesarwani, Jin H. Song, Myroslawa Soloshchenko, Jianing Fu, Stefanie R. Bailey, Chenthamarkshan Vasu, Andrew S. Kraft, Chrystal M. Paulos, Xue‐Zhong Yu, Shikhar Mehrotra

    Vydáno 2014
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  6. 6
    CD38–RyR2 axis–mediated signaling impedes CD8 <sup>+</sup> T cell response to anti-PD1 therapy in cancer

    CD38–RyR2 axis–mediated signaling impedes CD8 <sup>+</sup> T cell response to anti-PD1 therapy in cancer Autor Anwesha Kar, Puspendu Ghosh, Anupam Gautam, Snehanshu Chowdhury, Debashree Basak, Ishita Sarkar, Arpita Bhoumik, Shubhrajit Barman, Paramita Chakraborty, Asima Mukhopadhyay, Shikhar Mehrotra, Senthil Kumar Ganesan, Sandip Paul, Shilpak Chatterjee

    Vydáno 2024
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  7. 7
    A Quantitative Increase in Regulatory T Cells Controls Development of Vitiligo

    A Quantitative Increase in Regulatory T Cells Controls Development of Vitiligo Autor Shilpak Chatterjee, Jonathan M. Eby, Amir A. Al-Khami, Myroslawa Soloshchenko, Hee-Kap Kang, Navtej Kaur, Osama Naga, Anuradha K. Murali, Michael I. Nishimura, I. Caroline Le Poole, Shikhar Mehrotra

    Vydáno 2013
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  8. 8
    Intracellular Acetyl CoA Potentiates the Therapeutic Efficacy of Antitumor CD8+ T Cells

    Intracellular Acetyl CoA Potentiates the Therapeutic Efficacy of Antitumor CD8+ T Cells Autor Snehanshu Chowdhury, Anwesha Kar, Debaleena Bhowmik, Anupam Gautam, Debashree Basak, Ishita Sarkar, Puspendu Ghosh, Deborpita Sarkar, Alvina Deka, Paramita Chakraborty, Asima Mukhopadhyay, Shikhar Mehrotra, Soumen Basak, Sandip Paul, Shilpak Chatterjee

    Vydáno 2022
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  9. 9
    Metabolic reprogramming of alloantigen-activated T cells after hematopoietic cell transplantation

    Metabolic reprogramming of alloantigen-activated T cells after hematopoietic cell transplantation Autor Hung Nguyen, Shilpak Chatterjee, Kelley M.K. Haarberg, Yongxia Wu, David Bastian, Jessica Heinrichs, Jianing Fu, Anusara Daenthanasanmak, Steven Schutt, Sharad Shrestha, Chen Liu, Honglin Wang, Hongbo Chi, Shikhar Mehrotra, Xue‐Zhong Yu

    Vydáno 2016
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  10. 10
    Ccl22 Diverts T Regulatory Cells and Controls the Growth of Melanoma

    Ccl22 Diverts T Regulatory Cells and Controls the Growth of Melanoma Autor Jared Klarquist, Kristen Tobin, Peyman Farhangi Oskuei, Steven W. Henning, Manuel Fernández-Cañadas Fernández, Emilia R. Dellacecca, Flor Navarro, Jonathan M. Eby, Shilpak Chatterjee, Shikhar Mehrotra, Joseph I. Clark, I. Caroline Le Poole

    Vydáno 2016
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  11. 11
    Targeting PIM Kinase with PD1 Inhibition Improves Immunotherapeutic Antitumor T-cell Response

    Targeting PIM Kinase with PD1 Inhibition Improves Immunotherapeutic Antitumor T-cell Response Autor Shilpak Chatterjee, Paramita Chakraborty, Anusara Daenthanasanmak, Supinya Iamsawat, Gabriela Andrejeva, Libia A. Luevano, Melissa M. Wolf, Uday Baliga, Carsten Krieg, Craig C. Beeson, Meenal Mehrotra, Elizabeth G. Hill, Jeffery C. Rathmell, Xue‐Zhong Yu, Andrew S. Kraft, Shikhar Mehrotra

    Vydáno 2018
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  12. 12
    Thioredoxin-1 improves the immunometabolic phenotype of antitumor T cells

    Thioredoxin-1 improves the immunometabolic phenotype of antitumor T cells Autor Paramita Chakraborty, Shilpak Chatterjee, Pravin Kesarwani, Krishnamurthy Thyagarajan, Supinya Iamsawat, Annika V. Dalheim, Hung Nguyen, Shanmugam Panneer Selvam, Patrick Nasarre, Gina Scurti, Gary Hardiman, Nilanjana Maulik, Lauren E. Ball, Vamsi K. Gangaraju, Mark P. Rubinstein, Nancy Klauber‐DeMore, Elizabeth G. Hill, Besim Öğretmen, Xue‐Zhong Yu, Michael I. Nishimura, Shikhar Mehrotra

    Vydáno 2019
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  13. 13
    Nature and Dimensions of Systemic Hyperinflammation and its Attenuation by Convalescent Plasma in Severe COVID-19

    Nature and Dimensions of Systemic Hyperinflammation and its Attenuation by Convalescent Plasma in Severe COVID-19 Autor Purbita Bandopadhyay, Ranit D’Rozario, Abhishake Lahiri, Jafar Sarif, Yogiraj Ray, Shekhar Ranjan Paul, Rammohan Roy, Rajshekhar Maiti, Kausik Chaudhuri, Saugata Bagchi, Ayan Maiti, Mohammed Masoom Perwez, Biswanath Sharma Sarkar, Devlina Roy, Rahul Chakraborty, Janani Srinivasa Vasudevan, Sachin Sharma, Durba Biswas, Chikam Maiti, Bibhuti Saha, Prasun Bhattacharya, Rajesh Pandey, Shilpak Chatterjee, Sandip Paul, Dipyaman Ganguly

    Vydáno 2021
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  14. 14
    Pro-Survival Lipid Sphingosine-1-Phosphate Metabolically Programs T Cells to Limit Anti-tumor Activity

    Pro-Survival Lipid Sphingosine-1-Phosphate Metabolically Programs T Cells to Limit Anti-tumor Activity Autor Paramita Chakraborty, Silvia G. Vaena, Krishnamurthy Thyagarajan, Shilpak Chatterjee, Amir A. Al-Khami, Shanmugam Panneer Selvam, Hung Nguyen, In‐Hong Kang, Megan W. Wyatt, Uday Baliga, Zachariah Hedley, Rose N. Ngang, Beichu Guo, Gyda C. Beeson, Shahid Husain, Chrystal M. Paulos, Craig C. Beeson, Michael J. Zilliox, Elizabeth G. Hill, Meenal Mehrotra, Xue‐Zhong Yu, Besim Öğretmen, Shikhar Mehrotra

    Vydáno 2019
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  15. 15
    Carbon Monoxide Activates PERK-Regulated Autophagy to Induce Immunometabolic Reprogramming and Boost Antitumor T-cell Function

    Carbon Monoxide Activates PERK-Regulated Autophagy to Induce Immunometabolic Reprogramming and Boost Antitumor T-cell Function Autor Paramita Chakraborty, Rasesh Y. Parikh, Sang Ho Choi, Danh T. Tran, Mónika Göőz, Zachariah Hedley, Do‐Sung Kim, Dariusz Pytel, In‐Hong Kang, Satish N. Nadig, Gyda C. Beeson, Lauren E. Ball, Meenal Mehrotra, Hongjun Wang, Stefano Berto, Viswanathan Palanisamy, Hong Li, Shilpak Chatterjee, Paulo C. Rodrı́guez, Eduardo N. Maldonado, J. Alan Diehl, Vamsi K. Gangaraju, Shikhar Mehrotra

    Vydáno 2022
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  16. 16
    CD38-NAD+Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response

    CD38-NAD+Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response Autor Shilpak Chatterjee, Anusara Daenthanasanmak, Paramita Chakraborty, Megan W. Wyatt, Payal Dhar, Shanmugam Panneer Selvam, Jianing Fu, Jinyu Zhang, Hung Nguyen, In‐Hong Kang, Kyle Toth, Mazen Al-Homrani, Mahvash Husain, Gyda C. Beeson, Lauren E. Ball, Kristi L. Helke, Shahid Husain, Elizabeth Garrett‐Mayer, Gary Hardiman, Meenal Mehrotra, Michael I. Nishimura, Craig C. Beeson, Melanie Gubbels Bupp, Jennifer D. Wu, Besim Öğretmen, Chrystal M. Paulos, Jeffery C. Rathmell, Xue‐Zhong Yu, Shikhar Mehrotra

    Vydáno 2017
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  17. 17
    Clinical and immunological benefits of convalescent plasma therapy in severe COVID-19: insights from a single center open label randomised control trial

    Clinical and immunological benefits of convalescent plasma therapy in severe COVID-19: insights from a single center open label randomised control trial Autor Yogiraj Ray, Shekhar Ranjan Paul, Purbita Bandopadhyay, Ranit D’Rozario, Jafar Sarif, Abhishake Lahiri, Debaleena Bhowmik, Janani Srinivasa Vasudevan, Ranjeet Maurya, Akshay Kanakan, Sachin Sharma, Manish Kumar, Praveen Singh, Rammohan Roy, Kausik Chaudhury, Rajsekhar Maiti, Saugata Bagchi, Ayan Maiti, Md. Masoom Perwez, Abhinandan Mondal, Avinash Tewari, Samik Mandal, Arpan Roy, Moumita Saha, Durba Biswas, Chikam Maiti, Sayantan Chakraborty, Biswanath Sharma Sarkar, Anima Haldar, Bibhuti Saha, Shantanu Sengupta, Rajesh Pandey, Shilpak Chatterjee, Prasun Bhattacharya, Sandip Paul, Dipyaman Ganguly

    Vydáno 2020
    Získat plný text
    Pré-impressão
    Přidat do oblíbených
    Uloženo v:
  18. 18
    A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19

    A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19 Autor Yogiraj Ray, Shekhar Ranjan Paul, Purbita Bandopadhyay, Ranit D’Rozario, Jafar Sarif, Deblina Raychaudhuri, Debaleena Bhowmik, Abhishake Lahiri, Janani Srinivasa Vasudevan, Ranjeet Maurya, Akshay Kanakan, Sachin Sharma, Manish Kumar, Praveen Singh, Rammohan Roy, Kausik Chaudhury, Rajsekhar Maiti, Saugata Bagchi, Ayan Maiti, Md. Masoom Perwez, Abhinandan Mondal, Avinash Tewari, Samik Mandal, Arpan Roy, Moumita Saha, Durba Biswas, Chikam Maiti, Ritwik Bhaduri, Sayantan Chakraborty, Biswanath Sharma Sarkar, Anima Haldar, Bibhuti Saha, Shantanu Sengupta, Rajesh Pandey, Shilpak Chatterjee, Prasun Bhattacharya, Sandip Paul, Dipyaman Ganguly

    Vydáno 2022
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: